• Share
  • Email
  • Print
Photo Not Available

Claire H. Suni

Associate
+1.206.370.5970
Fax +1.206.623.7022
Claire Hansen Suni is an associate at the firm’s Seattle office. She is a member of the corporate/M&A practice group. She has represented public and privately held clients in cross border and domestic corporate transactions involving mergers, acquisitions, dispositions, joint ventures, debt and equity securities, and international projects.

Professional Background

Ms. Suni joined K&L Gates in 2020. Prior to joining the firm, Ms. Suni served as an associate at a global law firm where she focused her practice in mergers and acquisitions. In 2016 and 2017, Ms. Suni was seconded to a large trading company in Tokyo, Japan, where she advised on transactions across a broad spectrum of industries, including pharmaceuticals, healthcare, technology, and energy.

Professional/Civic Activities

  • Vice Chair, American Bar Association, Renewable, Alternative and Distributed Energy Resources (RADER) Committee
  • Fellow, Chayes International Public Service Program
  • Submissions Editor and Primary Editor, Harvard Human Rights Journal
  • Executive Board, Advocates for Human Rights
  • Karin Stromberg Award for Contributions to Social Justice
Mergers and Acquisitions
  • Represented a leading U.S. private equity firm and a New York-based hedge fund in their $855 million acquisition of a Portland, Oregon-based manufacturer of saw chain and other equipment for the forestry, agriculture and construction industries.
  • Represented an international financial services investment firm in its investment in the largest independent recordkeeping services provider, third-party administrator, and government savings facilitator in the United States
  • Represented a private Ophthalmology practice in its sale of a 60% ownership stake to a leading private equity firm
  • Represented a Japanese trading company in its acquisition of a 30% ownership stake in a Canadian renewable energy power generation project
  • Represented a multinational corporation that develops medical devices, pharmaceutical and consumer packaged goods in its sale of the rights to a hair care line to a large pharmaceutical company in the Europe, Middle East and Africa region; to a healthcare company in the Latin America region; and to an international healthcare business in the Asia Pacific region
  • Represented an American media conglomerate headquartered in Chicago, Illinois in its spin-off of a newspaper print and online media publishing company
  • Represented a privately owned medical device company in its acquisition of a manufacturer of non-invasive stimulation products for orthopedics and spine indications
  • Represented a Japanese trading company in the sale of a wholly-owned subsidiary that provides logistics services primarily to automotive manufacturers, to a global supply chain company
  • Represented a Japanese trading company in its acquisition of a 20% limited partnership interest in a full service truck leasing, truck rental and logistics business, from a global conglomerate offering commercial lending and leasing; consumer financing; and investments in alternative energy, aircraft leasing and financing
  • Represented a sovereign wealth fund owned by the government of a Persian Gulf state in its acquisition of a renewable energy power generation project in Eastern Africa
  • Represented a private equity firm with headquarters in Beijing, Hong Kong and Singapore in its acquisition of a 30% ownership stake in a global provider of administrative services for the alternative asset management industry
Financial Advisor Representation
  • Represented a global multinational investment bank and financial services company headquartered in Frankfurt, Germany as financial advisor to an American pharmaceutical company, in its $8 billion acquisition of an oncology research and development group
  • Represented a multinational investment bank and financial services holding company headquartered in New York City as financial advisor to a leading alternative asset manager, in its $8 billion merger with a non-traded business development company that primarily invests in senior secured debt
  • Represented a global independent investment banking advisory firm and a multinational investment bank as financial advisors to a biopharmaceutical company, in its $1.3 billion merger with a renal biopharmaceutical company
  • Represented a global multinational investment bank and financial services company headquartered in Frankfurt, Germany as financial advisor to a global specialty pharmaceutical company, in its $1.2 billion acquisition of a pharmaceutical company
  • Represented a global investment and advisory firm as financial advisor to a dermatology-focused pharmaceutical company, in the company’s all-stock merger with an Israeli biotechnology company
  • Represented a global wealth manager, investment bank and financial services company founded and based in Switzerland as financial advisor to a gaming company, in the $780 million sale of an urban casino and a horse racing track to a global leader in the entertainment and hospitality industry and a real estate investment trust specializing in casino properties
  • Represented a global investment and advisory firm as financial advisor to a commercial-stage biopharmaceutical company, in the company’s $504 million sale to a private equity and venture capital firm
Capital Markets
  • Represented an American healthcare company in its $1.1 billion secondary offering of common stock
  • Represented a global private equity manager, a multinational investment firm and a multi-asset alternative investment firm as selling shareholders in the $897 million secondary offering of common stock of one of the largest industrial distributors in North America
  • Represented a subsidiary of a financial services organization, in its offering of $1.0 billion of 2.950% senior notes due 2019 and $1.0 billion of 4.125% senior notes due 2024
  • Represented an American healthcare company in its offering of $750 million of senior notes
  • Represented an American healthcare company in its $612 million secondary offering of common stock
  • Represented a global private equity manager and a multinational investment firm as selling shareholders, in the $550 million secondary offering of common stock of one of the largest industrial distributors in North America